🇺🇸 FDA
Patent

US 7727980

Tricyclic androgen receptor modulator compounds and methods

granted A61PA61P1/14A61P13/08

Quick answer

US patent 7727980 (Tricyclic androgen receptor modulator compounds and methods) held by Ligand Pharmaceuticals Incorporated expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
64
CPC classes
A61P, A61P1/14, A61P13/08, A61P15/00, A61P15/08